Evaluation of Inhaled Dornase Alfa Administration in Non-Cystic Fibrosis Patients at a Tertiary Academic Medical Center
Conclusions:
Inhaled dornase alfa is commonly prescribed to improve atelectasis and secretions in a non-cystic fibrosis patient population at a tertiary academic medical center.
Source: Journal of Pharmacy Practice - Category: Drugs & Pharmacology Authors: Torbic, H., Hacobian, G. Tags: Research Articles Source Type: research
More News: Academia | Asthma | Chronic Obstructive Pulmonary | Cough | Cystic Fibrosis | Drugs & Pharmacology | Pulmozyme